Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cf-301 (4 trials)
Bacteremia (Phase 3)
Endocarditis (Phase 3)
Trials (4 total)
Trial APIs (1 total)